Equity Overview
Price & Market Data
Price: $5.00
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $9,507,350
Volume: 0
Performance Metrics
1 Week: 15.68%
1 Month: -20.94%
3 Months: -36.75%
6 Months: -33.29%
1 Year: -57.73%
YTD: -34.81%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.